New Alzheimer's Treatment Approved by the FDA, Not a Cure but Helps Slow Cognitive Decline

The FDA has approved a new drug that could help all those that suffer from Alzheimer’s disease. This is the first new Alzheimer’s drug approved in almost 20 years and targets proteins called amyloids that are thought to play a part in cognitive decline. More studies on its effectiveness will continue to be done and the treatment is very expensive, coming in at over $50,000 a year. Robert Langreth, science and health reporter at Bloomberg News, joins us for more. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com